John comes to Jessup with a background in biotechnology where he has extensive experience in cancer research and preclinical studies.  His pharmacology and oncology work with MMPI’s, VEGF inhibitors, and Hsp90 inhibitors has contributed to five Investigational New Drug filings.  One of those filings has resulted in a drug currently being prescribed for cancer treatment.  

John has a passion for team building, efficiency, and all things biology.  He is excited to use his expertise to facilitate and encourage the new generation of God-fearing scientists and health professionals.